The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $133.69

Today's change+0.62 +0.47%
Updated March 27 4:03 PM EDT. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $133.69

Today's change+0.62 +0.47%
Updated March 27 4:03 PM EDT. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc up (U.S.)$0.62

Thermo Fisher Scientific Inc closed up Friday by (U.S.)$0.62 or 0.47% to (U.S.)$133.69. Shares have lost 2.15% over the last five days, but sit 3.84% below their 52-week high. This security has outperformed the S&P 500 by 2.15% during the last year.

Key company metrics

  • Open(U.S.) $133.24
  • Previous close(U.S.) $133.07
  • High(U.S.) $134.52
  • Low(U.S.) $133.18
  • Bid / Ask(U.S.) $130.00 / (U.S.) $139.00
  • YTD % change+6.70%
  • Volume1,104,716
  • Average volume (10-day)2,225,593
  • Average volume (1-month)1,727,547
  • Average volume (3-month)1,862,709
  • 52-week range(U.S.) $107.33 to (U.S.) $139.03
  • Beta0.91
  • Trailing P/E28.36×
  • P/E 1 year forward18.15×
  • Forward PEG1.79×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.45%
  • Trailing EPS(U.S.) $4.71
Updated March 27 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.22%

Based on its net profit margin of 11.22%, Thermo Fisher Scientific Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.39%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 27, 201409/27/2014Jun 28, 201406/28/2014Mar 29, 201403/29/2014
Revenue4,4934,1714,3223,904
Total other revenue--------
Total revenue4,4934,1714,3223,904
Gross profit2,0921,9341,8471,620
Total cost of revenue2,4012,2382,4752,284
Total operating expense3,8543,5313,9743,028
Selling / general / administrative1,2241,2081,2391,202
Research & development183175184150
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)46-9076-607
Other operating expenses, total--------
Operating income639640348876
Interest income (expense), net non-operating-116-117-129-118
Gain (loss) on sale of assets--------
Other--------
Income before tax537539237774
Income after tax604470279543
Income tax, total-6769-42231
Net income601472279543
Total adjustments to net income--------
Net income before extra. items604470279543
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items604470279543
Inc. avail. to common incl. extra. items601472279543
Diluted net income602472279543
Dilution adjustment0----0
Diluted weighted average shares404404403398
Diluted EPS excluding extraordinary itemsvalue per share1.501.160.691.36
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.570.970.810.29